Oncotarget,
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
#PaperoftheDay: "From osimertinib to preemptive combinations" DOI ⬇️
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
Oncotarget #published this #research perspective on March 15, 2024 in Volume 15, entitled, “From osimertinib to preemptive…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
#PaperoftheDay: "From osimertinib to preemptive combinations" DOI: https://doi.org/10.18632/oncotarget.28569 #cancerresearch #o…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
On March 15, 2024, Dr. Blagosklonny from Roswell Park Comprehensive Cancer Center published a research perspective in Oncotarget…
NEW #PaperoftheDay: "From osimertinib to preemptive combinations" DOI: https://doi.org/10.18632/oncotarget.28569 #cancerresearc…
Oncotarget #published this #research perspective on March 15, 2024 in Volume 15, entitled, “From osimertinib to preemptive…